肝脏沙丘症:一个病例报告和文献综述
Eli A Zaher1, Mohamed A Ebrahim1, Parth Patel1
1Internal Medicine, Ascension Saint Joseph Hospital, Chicago, USA.
Cureus
|November 19, 2024
概括
本案例研究讨论了肝脏沙尔科毒症,这是沙尔科毒症的肝脏表现. 在患有这种罕见病症的患者中,乌尔索西胆酸治疗改善了症状.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 颗粒状疾病 颗粒状疾病
背景情况:
- Sarcoidosis是一种多系统的细粒体性疾病,病因不明.
- 肝脏干扰在肉类发病中很常见,但通常是无症状的.
- 症状性肝硬化症可能伴有胆固醇和肝酶升高.
研究的目的:
- 报告一种具有症状的肝脏沙尔科毒症病例.
- 讨论诊断挑战和肝脏沙尔科病的管理.
- 为了评估ursodeoxycholic酸在治疗肝脏沙丘病的疗效.
主要方法:
- 一个43岁的男性患有黄和的案例介绍.
- 实验室调查,包括肝功能测试和血管酶转化酶 (ACE) 水平.
- 图像学研究 (CT扫描) 评估中淋巴腺病和肝脏形态.
- 肝脏活检用于类发病的组织病理学确认.
主要成果:
- 患者呈现混合型高胆氨酸血症和肝酶升高.
- 图像检测显示了中淋巴腺病变和扩散性肝脏变化.
- 升高的ACE水平和肝脏活检证实了肝脏类固醇症.
- 用ursodeoxycholic酸治疗导致症状改善.
结论:
- 在患有无法解释的肝功能障碍的患者中,应考虑肝硬化症.
- 诊断需要临床,生化,成像和组织病理学发现的组合.
- 乌尔索多西胆酸可能是症状性肝硬化症的有益治疗选择.
相关概念视频
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


